Formulation and Characterization of Sustained-Release Drug Delivery Systems for Oral Cancer

Authors

  • Pranit Saraswat
  • Raviraj R. More
  • Netra Pal
  • Yogesh Matta
  • Evinka Barjataya
  • Madhu Sahu
  • V. Geetha
  • Dowluru SVGK Kaladhar
  • Neha Arora
  • Shraddha Walekar Ghaisas

DOI:

https://doi.org/10.52783/jns.v14.2869

Keywords:

Sustained-release drug delivery, oral cancer treatment, patient outcomes, therapeutic effectiveness, side effects, compliance, formulation optimization

Abstract

Clinical research explores sustained-release drug delivery systems used for oral cancer therapy and assesses the system effectiveness while reporting patient responses and reported adverse reactions. The research data verifies that the maintained drug concentrations are steady across extended periods while the extended delivery period enhances treatment results. Patients report negative experiences due to side effects yet the findings show the need for safe optimization of the therapy. The analysis underlines how strikes between elongated medication release duration and reduced unfavorable effects helps to better both patient treatment results and drug adherence. Sustained-release systems show promise in revolutionizing treatment protocols yet more development in formulation techniques remains essential for broadened use and higher effectiveness according to this research.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., ... &Nwanguma, B. C. (2023). Advances in drug delivery systems, challenges and future directions. Heliyon, 9(6).

Gharbavi, M., Amani, J., Kheiri-Manjili, H., Danafar, H., & Sharafi, A. (2018). Niosome: A promising nanocarrier for natural drug delivery through blood‐brain barrier. Advances in Pharmacological and Pharmaceutical Sciences, 2018(1), 6847971.

Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020). Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics, 12(3), 288.

He, S., Zhang, L., Bai, S., Yang, H., Cui, Z., Zhang, X., & Li, Y. (2021). Advances of molecularly imprinted polymers (MIP) and the application in drug delivery. European polymer journal, 143, 110179.

Kalaydina, R. V., Bajwa, K., Qorri, B., Decarlo, A., & Szewczuk, M. R. (2018). Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine, 4727-4745.

Ketabat, F., Pundir, M., Mohabatpour, F., Lobanova, L., Koutsopoulos, S., Hadjiiski, L., ... &Papagerakis, S. (2019). Controlled drug delivery systems for oral cancer treatment—current status and future perspectives. Pharmaceutics, 11(7), 302.

Meng, R., Wu, Z., Xie, Q. T., Cheng, J. S., & Zhang, B. (2021). Preparation and characterization of zein/carboxymethyl dextrin nanoparticles to encapsulate curcumin: Physicochemical stability, antioxidant activity and controlled release properties. Food Chemistry, 340, 127893.

Park, H., Otte, A., & Park, K. (2022). Evolution of drug delivery systems: From 1950 to 2020 and beyond. Journal of Controlled Release, 342, 53-65.

Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., ... & Shin, H. S. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16, 1-33.

Pham, D. T., &Tiyaboonchai, W. (2020). Fibroin nanoparticles: a promising drug delivery system. Drug delivery, 27(1), 431-448.

Rahman, H. S., Othman, H. H., Hammadi, N. I., Yeap, S. K., Amin, K. M., Abdul Samad, N., &Alitheen, N. B. (2020). Novel drug delivery systems for loading of natural plant extracts and their biomedical applications. International journal of nanomedicine, 2439-2483.

Samimi, S., Maghsoudnia, N., Eftekhari, R. B., &Dorkoosh, F. (2019). Lipid-based nanoparticles for drug delivery systems. Characterization and biology of nanomaterials for drug delivery, 47-76.

Sarma, S., Agarwal, S., Bhuyan, P., Hazarika, J., & Ganguly, M. (2022). Resveratrol-loaded chitosan–pectin core–shell nanoparticles as novel drug delivery vehicle for sustained release and improved antioxidant activities. Royal Society open science, 9(2), 210784.

Shah, M. K. A., Azad, A. K., Nawaz, A., Ullah, S., Latif, M. S., Rahman, H., ... & Abdel-Daim, M. M. (2021). Formulation development, characterization and antifungal evaluation of chitosan NPs for topical delivery of voriconazole in vitro and ex vivo. Polymers, 14(1), 135.

Singh, S., Vijayakumar, M. R., &Dewangan, H. K. (2018). Lipid based aqueous core nanocapsules (ACNs) for encapsulating hydrophillic vinorelbine bitartrate: preparation, optimization, characterization and in vitro safety assessment for intravenous administration. Current drug delivery, 15(9), 1284-1293.

Downloads

Published

2025-04-01

How to Cite

1.
Saraswat P, R. More R, Pal N, Matta Y, Barjataya E, Sahu M, Geetha V, SVGK Kaladhar D, Arora N, Walekar Ghaisas S. Formulation and Characterization of Sustained-Release Drug Delivery Systems for Oral Cancer. J Neonatal Surg [Internet]. 2025Apr.1 [cited 2025Oct.5];14(10S):509-17. Available from: https://jneonatalsurg.com/index.php/jns/article/view/2869

Most read articles by the same author(s)